TotalMarketCap

Oramed Pharmaceuticals

ORMPNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$162.646 M

$3.91 -5.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Oramed Pharmaceuticals (ORMP) has a market capitalization of $162.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.00M

#3398 by revenue

Earnings

$75.3K

#2429 by earnings

Shares outstanding

41,597,354

Latest filing cover page

P/E ratio

2159.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #257Whitehawk TherapeuticsWHWK$173.9M
  2. #258Zentalis PharmaceuticalsZNTL$162.8M
  3. #259Oramed PharmaceuticalsORMP$162.6M
  4. #260PepGenPEPG$160.3M
  5. #261Canton StrategicCNTN$152.6M

What if Oramed Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$678,814.18

Per share 173,610× higher

Bitcoin $1.53T

$36,729.45

Per share 9,394× higher

Apple $5.02T

$120,579.37

Per share 30,839× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Oramed Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.